2D model showing how the pluripotent stem cells react to human relevant doses of cadmium over 8 days. From the control in the first panel, to the last panel, researchers can see how the differentiation to cardiomyocytes is inhibited with different doses of cadmium.
News | Congenital Heart
New 3D Model Shows How Cadmium Exposure May Affect Heart Development

November 2, 2022 — Researchers have developed a three-dimensional model that shows how exposure to cadmium might lead to ...

Home November 02, 2022
Home
News | VIVA
VIVA Foundation Symposium presents Clinical Trial Findings

November 2, 2022 — The second round of late-breaking clinical trial results were announced at VIVA22 on Nov. 1 in Las ...

Home November 02, 2022
Home
News | VIVA
The VEINS/VIVA 2022 Top Awards Recognize Leaders in Vascular Medicine

November 2, 2022 — A number of awards of distinction were presented during The VEINS (Venous Endovascular INterventional ...

Home November 02, 2022
Home
Deepak L. Bhatt, MD, MPH
News | Cardiovascular Business
Deepak L. Bhatt, MD, MPH, Named Director of Mount Sinai Heart

November 1, 2022 — Deepak L. Bhatt, MD, MPH, a top expert in cardiovascular medicine and interventional cardiology, has ...

Home November 01, 2022
Home
Proxy allows for seamless data transmission and improved AI-based plaque analysis
News | Computed Tomography (CT)
Cleerly Introduces Proxy Solution to Improve Heart Disease Imaging Workflows

November 1, 2022 — Cleerly, the company creating a new standard of care for heart disease, announced a new workflow ...

Home November 01, 2022
Home
Impella RP Flex with SmartAssist Illustration (Photo: Business Wire)
News | Hemodynamic Support Devices
Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure

November 1, 2022 — Abiomed announced that Impella RP Flex with SmartAssist has received U.S. Food and Drug ...

Home November 01, 2022
Home
Johnson & Johnson to Acquire Abiomed
Feature | Cardiovascular Business
Johnson & Johnson to Acquire Abiomed

November 1, 2022 — Johnson & Johnson and Abiomed, a world leader in breakthrough heart, lung and kidney support ...

Home November 01, 2022
Home
DAIC's Top 10 for the month of October
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: What Viewers Were Reading in October

Here is what you and your colleagues found to be most interesting in the fields of diagnostic and interventional ...

Home November 01, 2022
Home
News | VIVA
Clinical Trials on Venous Care presented at THE VEINS 2022

October 31, 2022 — Results from the Late-Breaking Clinical Trials session at The VEINS Conference in Las Vegas, NV, were ...

Home October 31, 2022
Home
Barry L. Zaret, MD (Image courtesy of Yale School of Medicine)
News | Cardiovascular Business
The Industry Remembers Barry L. Zaret, MD

October 31, 2022 — The Yale School of Medicine announced the passing of Robert W. Berliner Professor Emeritus of ...

Home October 31, 2022
Home
Cedars-Sinai investigators are evaluating novel AI approaches and exploring how these models can be integrated in standard patient care. Image courtesy of Cedars-Sinai
News | SPECT Imaging
AI Improves Accuracy of Heart Condition Diagnosis

October 31, 2022 — Several recent discoveries show that the accuracy of diagnosing coronary artery disease and ...

Home October 31, 2022
Home
An artist's rendering shows how a new pacemaker, designed by a UArizona-led team of researchers, is able to envelop the heart. The wireless, battery-free pacemaker could be implanted with a less invasive procedure than currently possible and would cause patients less pain. Illustration credit: Philipp Gutruff
News | Atrial Fibrillation
Battery-Free, Light-Powered Pacemaker May Improve Quality of Life for Heart Disease Patients

October 31, 2022 — Atrial fibrillation – a form of irregular heartbeat, or arrhythmia – leads to more than 454,000 ...

Home October 31, 2022
Home
Patent builds on previously granted U.S. patent as well as strengthens and diversifies the IP portfolio and further protects future revenues
News | ECG
HeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista ECG

October 28, 2022 — Heart Test Laboratories, Inc., a medical technology company focused on saving lives by making an ECG ...

Home October 28, 2022
Home
The RELIEVE-HF trial of the Ventura Shunt System includes patients with reduced and preserved left ventricular function etiologies for heart failure
News | Heart Failure
V-Wave Completes Enrollment in the RELIEVE-HF Randomized Double-Blind Controlled Trial of Interatrial Shunting for Heart Failure

October 28, 2022 — V-Wave, announced today the completion of enrollment in RELIEVE-HF, a prospective, randomized, double ...

Home October 28, 2022
Home
SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, has received FDA Investigational Device Exemption (IDE) approval to initiate its coronary pivotal clinical trial.
News | Drug-Eluting Balloons
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval

October 28, 2022 — SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, has received FDA Investigational Device ...

Home October 28, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now